Skládal M, Pink M, Lisý M, Novotný L
Ortopedické oddelení nemocnice Trebíc, Trebic.
Acta Chir Orthop Traumatol Cech. 2009 Jun;76(3):202-7.
To present a new type of percutaneous compression plate (PCP) for a minimally invasive method of treating trochanteric hip fractures.
Between September 2004 and December 2006, a total of 66 patients with hip fractures were treated by minimally invasive percutaneous osteosynthesis involving a PCP. The average age of the patients was 74.5 years (range, 27-95 years). The fractures were classified as pertrochanteric (AO31, A1.1-A2.3) in 73%, femoral neck fracture (AO31, B2) in 20%, and intertrochanteric fracture (AO31, A3.1) in 7% of the patients.
Reduction was performed under conduction or general anaesthesia on a traction table, using an X-ray image intensifier system. Reduction and intra-operative temporary stabilisation of the fracture was facilitated by a posterior reduction device. Access was gained and a PCP was inserted through two incisions at the lateral side of the proximal femur.
The patients were followed up for at least 6 months. Radiographic union was found on average at 3 months post-operatively. No pseudoarthrosis or implant failure was recorded. At 6-month follow-up, 81% of the patients were able to walk without walking aid or with one walking cane only. Two crutches were used by 8% of the patients.To walk without help was impossible for 11% of the patients whose mobility had already been limited before the injury.
PCP osteosynthesis for trochanteric fractures is a novel minimally invasive approach providing a better treatment of the fracture. Compared to dynamic hip screw osteosynthesis used before, PCP allows for earlier weight bearing and noticeably reduces blood loss. Implant construction as well as post-operative controlled impaction of the fracture minimize the risk of osteosynthesis failure. The simple instrumentation construction enables us to reduce operative time.
The percutaneous compression plate is a contribution to minimally invasive osteosynthesis of trochanteric fractures. An increase in rotational stability of the implant due to its biaxial telescopic construction allows for earlier weight-bearing of the extremity, thus facilitating the patient's earlier return to everyday life activities. It also reduces operative trauma, blood loss and post-operative complications.
介绍一种新型经皮加压钢板(PCP),用于微创治疗股骨转子间骨折。
2004年9月至2006年12月期间,共有66例髋部骨折患者接受了采用PCP的微创经皮接骨术治疗。患者的平均年龄为74.5岁(范围为27 - 95岁)。73%的患者骨折分类为转子周围骨折(AO31,A1.1 - A2.3),20%为股骨颈骨折(AO31,B2),7%为转子间骨折(AO31,A3.1)。
在牵引台上采用传导麻醉或全身麻醉,使用X线影像增强系统进行复位。通过后路复位装置辅助骨折复位及术中临时固定。通过股骨近端外侧的两个切口进入并插入PCP。
对患者进行了至少6个月的随访。术后平均3个月时发现影像学骨愈合。未记录到假关节或植入物失败情况。在6个月随访时,81%的患者能够无需辅助行走或仅使用一根拐杖行走。8%的患者使用两根拐杖。11%受伤前活动能力就已受限的患者无法独立行走。
PCP接骨术治疗转子间骨折是一种新型微创方法,能更好地治疗骨折。与之前使用的动力髋螺钉接骨术相比,PCP允许更早负重并显著减少失血。植入物结构以及骨折术后的控制性嵌插可将接骨失败风险降至最低。简单的器械结构使我们能够缩短手术时间。
经皮加压钢板有助于股骨转子间骨折的微创接骨术。由于其双轴伸缩结构,植入物的旋转稳定性增加,允许肢体更早负重,从而促进患者更早恢复日常生活活动。它还减少了手术创伤、失血和术后并发症。